July 26, 2012, NewBio Therapeutic (NBT) announced today we have signed collaboration agreement with REMD Biotherapeutics (Thousand Oaks, California, USA) for protein-toxin drug therapeutics development. This is a very import strategy for NBT to develop and commercialize innovative products and to supplement our internal pipeline. REMD will develop large molecules for oncology targets and NBT provides their proprietary linker and conjugation technology to make protein-toxin conjugates as anticancer therapeutics.
July 26, 2012, NewBio Therapeutic (NBT) announced today we have signed collaboration agreement with REMD Biotherapeutics (Thousand Oaks, California, USA) for protein-toxin drug therapeutics development. This is a very import strategy for NBT to develop and commercialize innovative products and to supplement our internal pipeline. REMD will develop large molecules for oncology targets and NBT provides their proprietary linker and conjugation technology to make protein-toxin conjugates as anticancer therapeutics.